1. Home
  2. CISO vs MYNZ Comparison

CISO vs MYNZ Comparison

Compare CISO & MYNZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CISO
  • MYNZ
  • Stock Information
  • Founded
  • CISO 2015
  • MYNZ 2021
  • Country
  • CISO United States
  • MYNZ Germany
  • Employees
  • CISO N/A
  • MYNZ N/A
  • Industry
  • CISO Computer Software: Prepackaged Software
  • MYNZ Biotechnology: Pharmaceutical Preparations
  • Sector
  • CISO Technology
  • MYNZ Health Care
  • Exchange
  • CISO Nasdaq
  • MYNZ Nasdaq
  • Market Cap
  • CISO 8.0M
  • MYNZ 9.8M
  • IPO Year
  • CISO N/A
  • MYNZ 2021
  • Fundamental
  • Price
  • CISO $0.59
  • MYNZ $0.38
  • Analyst Decision
  • CISO
  • MYNZ Buy
  • Analyst Count
  • CISO 0
  • MYNZ 2
  • Target Price
  • CISO N/A
  • MYNZ $3.00
  • AVG Volume (30 Days)
  • CISO 78.4K
  • MYNZ 1.4M
  • Earning Date
  • CISO 08-07-2024
  • MYNZ 08-13-2024
  • Dividend Yield
  • CISO N/A
  • MYNZ N/A
  • EPS Growth
  • CISO N/A
  • MYNZ N/A
  • EPS
  • CISO N/A
  • MYNZ N/A
  • Revenue
  • CISO $55,165,412.00
  • MYNZ $895,479.00
  • Revenue This Year
  • CISO $78.76
  • MYNZ $67.40
  • Revenue Next Year
  • CISO N/A
  • MYNZ $191.13
  • P/E Ratio
  • CISO N/A
  • MYNZ N/A
  • Revenue Growth
  • CISO 8.28
  • MYNZ 69.00
  • 52 Week Low
  • CISO $0.54
  • MYNZ $0.32
  • 52 Week High
  • CISO $3.60
  • MYNZ $4.79
  • Technical
  • Relative Strength Index (RSI)
  • CISO 39.04
  • MYNZ 39.67
  • Support Level
  • CISO $0.54
  • MYNZ $0.39
  • Resistance Level
  • CISO $0.65
  • MYNZ $0.46
  • Average True Range (ATR)
  • CISO 0.04
  • MYNZ 0.08
  • MACD
  • CISO 0.01
  • MYNZ 0.01
  • Stochastic Oscillator
  • CISO 40.83
  • MYNZ 26.53

About CISO CISO Global Inc.

CISO Global Inc provides cybersecurity services. The services are used to protect client's data, financial information, intellectual property, and business reputation. The services include penetration testing, security remediation, compliance auditing, vulnerability assessment, and others. Geographically, the company operates in U.S., Chile and All other countries. The maximum revenue is generated from U.S.

About MYNZ Mainz Biomed N.V.

Mainz Biomed NV develops market-ready molecular genetic diagnostic solutions for life-threatening conditions. The company's flagship product is ColoAlert, is an accurate, non-invasive and easy-to-use, early-detection diagnostic test for colorectal cancer based on real-time Polymerase Chain Reaction-based (PCR) multiplex detection of molecular-genetic biomarkers in stool samples.

Share on Social Networks: